Journals / Genel Tıp Dergisi / 2022 / Cilt: 32 - Sayı: 6

Hybrid Cardiovascular Surgery

Hibrid Kardiyovasküler Cerrahi

Pages
796–801
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With the developing technology, new hybrid procedures can be created for myocardial revascularization, heart valve diseases, aortic and peripheral vascular diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Today, cardiologists and cardiovascular surgeons are more likely to encounter patients with multiple comorbidities and cardiovascular diseases.
📊
Key Findings & Data:Percutaneous and surgical techniques alone cannot be successful or are high risk in these patients.
💡
Conclusion & Impact:With the developing technology, new hybrid procedures can be created for myocardial revascularization, heart valve diseases, aortic and peripheral vascular diseases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:hibrid cerrahi · kalp ve damar cerrahisi · kardiyovasküler hastalıklar

Abstract

Today, cardiologists and cardiovascular surgeons are more likely to encounter patients with multiple comorbidities and cardiovascular diseases. Percutaneous and surgical techniques alone cannot be successful or are high risk in these patients. By using the strengths of the two methods in a hybrid manner, low-risk procedures can be performed in these patients. With the developing technology, new hybrid procedures can be created for myocardial revascularization, heart valve diseases, aortic and peripheral vascular diseases.

Özet

Gümünüzde kardiyologlar ve kardiyovasküler cerrahlar birden çok komorbiditeye ve kardiyovasküler hastalığa sahip hasta grubuyla daha sık karşılaşmakta. Perkutan ve cerrahi teknikler bu hastalarda tek başına başarı sağlayamamakta veya yüksek riskli olmakta. İki yöntemin güçlü yönlerini hibrid bir şekilde kullanarak bu hastalarda düşük riskli prosedürler gerçekleştirilebilmektedir. Gelişen teknoloji ile birlikte miyokardiyal revaskülarizasyon, kalp kapak hastalıkları, aort ve periferik damar hastalıkları için yeni hibrid prosedürler oluşturulabilmektedir.

🔖

Cite This Article

YALÇINKAYA, A., YENER, A. Ü., DARÇIN, O. T. (2022). Hybrid Cardiovascular Surgery. Genel Tıp Dergisi, Cilt: 32 - Sayı: 6, 796–801. https://ajindex.com/articles/879123

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Umakanthan R, Leacche M, Zhao DX, Gallion AH, Mishra PC, Byrne JG. Hybrid options for treating cardiac disease. Semin Thorac Surg 2011;23:274-280
  2. Papakonstantinou NA, Baikoissis NG, Dedeilias P, Argiriou M, Charitos C. Cardiac surgery or interventional cardiology? Why not both? Let’s go hybrid. J Cardiol 2017;69:46-56
  3. Angelini GD, Wilde P, Salerno TA, Bosco G, Calafiore AM. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet 1996;(16)347:757-8
  4. Hage A, Giambruno V, Jones P, Chu MW, Fox S, Teefy P, et al. Hybrid coronary revascularisation versus off-pump coronary artery bypass grafting: comparative effectiveness analysis with long-term follow-up. J Am Heart Assoc 2019;8:E014204
  5. Saha T, Naqvi SY, Goldberg S. Hybrid revascularisation: a review. Cardiology 2018;140:35-44
  6. Giambruno V, Jones P, Khaliel F, Michael W, Chu MW, Teefy P, et al. Hybrid coronary revascularization versus on-pump coronary artery bypass grafting. Ann Thorac Surg 2018;105(5):1330-5
  7. Kitahara H, Hirai T, McCorey M, Patel B, Nisivaco S, Nathan S, et al. Hybrid coronary revascularisation: midterm outcomes of robotic multivessel bypass and percutaneous interventions. J Thorac Cardiovasc Surg 2019;157:1829-36
  8. Leacche M, Byrne JG, Solenkova NS, Reagan B, Mohamed TI, Fredi JL, et al. Comparision of 30-day outcomes of coronary artery bypass grafting surgery versus hybrid coronary revascularisation strafied by SYNTAX and euroSCORE. J Thorac Cardiovasc Surg 2013;145:1004-12
  9. Tajstra M, Hrapkowicz T, Hawranek M, Filipiak K, Gierlotka M, Zembala M, et al. Hybrid coronary revascularisation in selected patients with multivessel disease. 5-year clinical outcomes of the prospective randomized pilot study. J Am Coll Cardiol Intv 2018;11847-52
  10. George I, Nazif TM, Kalesan B, Kriegel J, Yerebakan H, Kirtane A, et al. Feasibility and early safety of single-stage hybrid coronary intervention and valvular cardiac surgery Ann Thorac Surg. 2015;99(6):2032-7
  11. Santana O, Xydas S, Williams RF, LaPietra A, Mawad M, Wigley JC, et al. Percutaneous coronary intervention followed by minimally invasive valve surgery compared with median sternotomy coronary artery bypass graft and valve surgery in patients with prior cardiac surgery. J Thorac Dis 2017;9(Suppl 7):S575-81
  12. Marcus SG, Mahadevan VS, Deuse T. Hybrid open minimally invasive transcatheter mitral valve replacement Ann Thorac Surg 2018;106:e57-9
  13. Preventza O, Af